# Cancer Treatment * **Definition:** The medical procedures and therapies used to treat cancer, which can include surgical, radiologic, and systemic treatments such as chemotherapy, radiation therapy, and immunotherapy, aimed at eliminating cancer cells and improving patient health. * **Taxonomy:** Healthcare Topics / Cancer Treatment ## News * Selected news on the topic of **Cancer Treatment**, for healthcare technology leaders * 31.6K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/27/2025 | [**Rural Healthcare Challenges: How AI & Telemedicine Can Improve Access - HIT Consultant**](https://hitconsultant.net/2025/05/27/rural-healthcare-challenges-how-ai-telemedicine-can-improve-access/) | [[HIT Consultant]] | | 5/27/2025 | [**AstraZeneca (LSE:AZN) Gains EU Recommendation For Imfinzi in Bladder Cancer Treatment**](https://finance.yahoo.com/news/astrazeneca-lse-azn-gains-eu-172511773.html) | [[Yahoo Finance]] | | 5/14/2025 | [**Nanotechnology In Cancer Treatment Market Competitive Landscape and Forecast Analysis**](https://www.linkedin.com/pulse/nanotechnology-cancer-treatment-market-competitive-ww4kf) | [[Linkedin]] | | 5/13/2025 | [**Complement 1 Secures $16M for Clinically Validated Cancer Lifestyle Modification Platform**](https://hitconsultant.net/2025/05/13/complement-1-secures-16m-for-clinically-validated-cancer-lifestyle-modification-platform/) | [[HIT Consultant]] | | 4/23/2025 | [**Former NCI director appointed CEO of Ohio State cancer center**](https://www.beckershospitalreview.com/oncology/former-nci-director-appointed-ceo-of-ohio-state-cancer-center/) | [[Beckers Hospital Review]] | | 4/23/2025 | [**Stanford Medicine blood test detects cancer: What to know**](https://www.beckershospitalreview.com/oncology/stanford-medicine-blood-test-detects-cancer-what-to-know/) | [[Beckers Hospital Review]] | | 4/19/2025 | [**Iran, US hold talks in Rome in bid to reach nuclear deal - AOL.com**](https://www.aol.com/news/iran-us-hold-talks-rome-030431113.html) | [[AOL]] | | 4/11/2025 | [**UVA researcher wins major grant to revolutionize breast cancer treatment**](https://www.news-medical.net/news/20250411/UVA-researcher-wins-major-grant-to-revolutionize-breast-cancer-treatment.aspx) | [[News Medical Net]] | | 2/21/2025 | [**Roundup: AI and cloud tackle cyber risk and improve workflows - Healthcare IT News**](https://www.healthcareitnews.com/news/roundup-ai-and-cloud-tackle-cyber-risk-and-improve-workflows) | [[Healthcare IT News]] | | 1/21/2025 | [**Alarming trend highlights American Cancer Society's annual report - Yahoo**](https://www.yahoo.com/news/alarming-trend-highlights-american-cancer-190031978.html) | [[Yahoo]] | | 1/13/2025 | [**First Ascent Biomedical Secures $6 Million Investment from Vidal Duart Enterprises, Inc. to ...**](https://www.businesswire.com/news/home/20250113177279/en/First-Ascent-Biomedical-Secures-6-Million-Investment-from-Vidal-Duart-Enterprises-Inc.-to-Revolutionize-Cancer-Treatment) | [[Business Wire]] | | 1/9/2025 | [**Mussel-inspired nanoparticles for targeted lung cancer therapy**](https://www.news-medical.net/news/20250109/Mussel-inspired-nanoparticles-for-targeted-lung-cancer-therapy.aspx) | [[News Medical Net]] | | 12/20/2024 | [**Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic ...**](https://www.businesswire.com/news/siliconvalley/20241220937037/en) | [[Business Wire]] | | 12/13/2024 | [**Heart-related side effects of cancer treatment must be addressed as early as possible, experts say**](https://medicalxpress.com/news/2024-12-heart-side-effects-cancer-treatment.html) | [[MedicalXpress]] | | 12/13/2024 | [**DukeHealth to build proton therapy center with $50M gift**](https://www.beckershospitalreview.com/oncology/dukehealth-to-build-proton-therapy-center-with-50m-gift.html) | [[Beckers Hospital Review]] | | 12/13/2024 | [**OhioHealth to open $226M outpatient cancer center**](https://www.beckershospitalreview.com/oncology/ohiohealth-to-open-226m-outpatient-cancer-center.html) | [[Beckers Hospital Review]] | | 12/12/2024 | [**Atossa Therapeutics Announces Discovery of Synergistic Compounds for (Z) - Nasdaq**](https://www.nasdaq.com/articles/atossa-therapeutics-announces-discovery-synergistic-compounds-z-endoxifen-breast-cancer) | [[Nasdaq]] | | 12/9/2024 | [**Texas Medical Center Expands Global Impact with Launch of TMC Japan BioBridge and ...**](https://www.businesswire.com/news/home/20241209076741/en/Texas-Medical-Center-Expands-Global-Impact-with-Launch-of-TMC-Japan-BioBridge-and-JACT-Program) | [[Business Wire]] | | 12/9/2024 | [**Texas Medical Center Expands Global Impact with Launch of TMC Japan BioBridge and JACT Program**](http://www.businesswire.com/news/home/20241209076741/en/Texas-Medical-Center-Expands-Global-Impact-with-Launch-of-TMC-Japan-BioBridge-and-JACT-Program/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/3/2024 | [**Adaptive Research Welcomes Western Radiation Oncology to Expand Community Access to Pioneering Cancer Treatment Trials**](https://markets.businessinsider.com/news/stocks/adaptive-research-welcomes-western-radiation-oncology-to-expand-community-access-to-pioneering-cancer-treatment-trials-1034096437) | [[Business Insider Markets]] | | 11/17/2024 | [**Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy**](https://markets.businessinsider.com/news/stocks/trogenix-unveils-revolutionary-platform-to-transform-cancer-treatment-through-precision-viral-immunotherapy-1034030080) | [[Business Insider Markets]] | | 11/17/2024 | [**4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy**](https://markets.businessinsider.com/news/stocks/4bio-capital-portfolio-company-trogenix-unveils-revolutionary-platform-to-transform-cancer-treatment-through-precision-viral-immunotherapy-1034030107) | [[Business Insider Markets]] | | 9/6/2024 | [**Moving the bar(rier) forward: the benefits of de-risking cytokine release syndrome**](https://thehealthcareblog.com/blog/2024/09/06/headline-moving-the-barrier-forward-the-benefits-of-de-risking-cytokine-release-syndrome/) | [[The Health Care Blog]] | | 8/4/2024 | [**North America region is expected to dominate the Bone Cancer Treatment Market growth potential during the forecast period**](http://prsync.com/maximize-market-research-company/north-america-region-is-expected-to-dominate-the-bone-cancer-treatment-market-growth-potential-during-the-forecast-period-4231063/) | [[PRSync]] | | 7/10/2024 | [**Med-Tech and Automation trends in the medical devices industry - Infiniti Research**](https://www.infinitiresearch.com/thoughts/medical-device-industry-trends-automation/) | infinitiresearch.com | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Virginia Tech**: Researchers exploring the modification of biomaterials to improve cancer treatment efficacy. - **National Cancer Center of Japan**: A key player in the TMC Japan BioBridge initiative aimed at improving cancer treatment through international collaboration. - **Texas Medical Center**: A leading medical institution in the U.S. focused on enhancing cancer treatment through collaboration and innovation. - **Moffitt Cancer Center**: Developed a new vaccine strategy targeting HER2-positive breast cancer, showing promising results in clinical trials. - **Vivan Therapeutics**: Utilizes AI to create personalized cancer treatments based on unique tumor profiles. - **Hoth Therapeutics**: A company developing therapies to alleviate skin toxicities in cancer patients. - **McKesson**: Healthcare company leading the Precision Care Companion initiative to enhance cancer treatment through genomic testing. - **Caris Life Sciences**: A leader in molecular profiling services that tailors cancer treatments to individual patients based on genetic and molecular data. - **Onco-Innovations Limited**: A company dedicated to pioneering cancer research and treatment, focusing on advanced therapies and collaborations to improve patient outcomes. - **Foundation Medicine**: A leader in genomic profiling and precision medicine solutions for cancer treatment. - **OS Therapies, Inc.**: A biopharmaceutical company enhancing its cancer treatment pipeline through the acquisition of immuno-oncology programs. - **Community Oncology Partners (COP)**: Partnered with CBRE to enhance the development of medical oncology sites for improved access to cancer care. - **Mass General Brigham**: Investing $400 million to establish a new cancer treatment institute, enhancing cancer care infrastructure. - **Novartis**: A global healthcare company focusing on innovative medicines, particularly in oncology, with a robust pipeline of cancer treatments. - **Boehringer Ingelheim**: A global pharmaceutical company enhancing its cancer treatment portfolio through licensing ADC technology from Synaffix. - **Byondis B.V.**: Focused on developing targeted cancer treatments, particularly antibody-drug conjugates. - **King Faisal Specialist Hospital & Research Centre**: Achieved significant cost reductions in CAR T-cell therapy production, enhancing treatment availability. - **Boston Scientific Corporation**: A medical technology company acquiring Intera Oncology to enhance liver cancer treatment capabilities. - **Tempest Therapeutics**: Biopharmaceutical company developing amezalpat, a novel cancer treatment with immune-mediated mechanisms. - **Oracle Health**: Provides electronic health record solutions to enhance cancer care through improved data access and treatment planning. ### Partnerships and Collaborations - **CancerVax and Dr. Sumant Ramachandra**: Appointment of a new Chief Scientific Advisor to guide the development of an innovative cancer treatment platform. - **Survivor Healthcare and Utah Cancer Specialists**: Partnered to enhance supportive care for cancer patients through a telehealth platform. - **Florida Cancer Specialists and the Cancer Moonshot initiative**: Working to eliminate barriers to cancer treatment and improve health equity. - **Onco-Innovations and Quantify Research**: Collaboration to leverage AI-driven predictive modeling for enhancing cancer treatment insights. - **Outcomes Matter Innovations and Regional Cancer Care Associates**: A co-development agreement to optimize point-of-care decision support capabilities for cancer treatment. - **Massive Bio Collaborations**: Collaborated with numerous pharmaceutical companies and research organizations to enhance cancer treatment access. - **Adaptive Research and Western Radiation Oncology**: This collaboration focuses on enhancing access to innovative cancer treatment trials for patients in the San Francisco Bay Area. - **Community Oncology Partners and CBRE**: Collaborating to develop state-of-the-art oncology facilities to improve access to cancer care. - **LC-SCRUM-CD**: A nationwide clinical trial network in Japan for individualized lung cancer treatment, involving multiple institutions. - **Novartis and Ratio Therapeutics**: Developing a cancer treatment targeting somatostatin receptor 2. - **Adaptive Research and WRO**: Collaboration to enhance access to innovative cancer treatment trials in the San Francisco Bay Area. - **Exact Sciences**: Collaborating with breast cancer experts to present findings at the San Antonio Breast Cancer Symposium, showcasing advancements in precision oncology. - **TMC Japan BioBridge**: A collaboration between Texas Medical Center, Mitsui Fudosan, and the National Cancer Center of Japan to enhance cancer treatment and facilitate U.S. market access for Japanese companies. - **Boehringer Ingelheim and Synaffix**: Licensed ADC technology to develop targeted cancer therapies. - **Sanofi and Exscientia**: Collaboration to utilize AI for developing new cancer treatments. - **Bharath Advanced Therapeutics (BAT)**: Organized the Cancer NEXT 2024 conference to showcase research and support emerging researchers. - **University of Queensland and AdvanCell**: Partnership aimed at transforming prostate cancer treatment through targeted alpha therapies. - **J INTS BIO and Yonsei University**: A collaboration aimed at revolutionizing cancer treatment through AI-driven precision oncology. - **Institut Curie and Spotlight Medical**: A strategic alliance combining clinical expertise and extensive data to develop innovative cancer solutions. - **Horizon IHI Project**: A European initiative aiming to develop new cancer treatment tools using advanced imaging and AI for personalized therapies. ### Innovations, Trends, and Initiatives - **CancerMPact Treatment Architecture**: Oracle's cloud-based utility for analyzing global cancer treatment patterns to inform pharmaceutical companies. - **Financial Assistance Initiatives**: Efforts to provide financial assistance for cancer treatment costs, including exploring insurance options. - **Medical Cannabis**: Growing support for its use in cancer treatment, particularly for managing symptoms and alleviating chemotherapy side effects. - **AI in Cancer Treatment**: The integration of AI and machine learning in drug discovery and treatment selection is reshaping cancer care. - **CAR T-cell Therapy**: A groundbreaking treatment involving genetic modification of T cells to target and eliminate cancer cells, with FDA approval in 2017. - **Liquid Biopsy Technology**: Revolutionizing cancer treatment by providing real-time insights into cancer progression for timely interventions. - **Immunotherapy Advancements**: Innovations in immunotherapy are harnessing the immune system to target and destroy cancer cells, offering alternatives to traditional treatments. - **AI in Oncology**: Transforming practices by facilitating early screening and personalized treatment plans. - **mRNA Technology**: Potential to revolutionize cancer treatment by engaging the immune system for anti-tumor responses. - **Cardio-Oncology Integration**: The European Society of Cardiology emphasizes integrating cardiovascular health into cancer treatment plans to improve patient outcomes. - **Antibody-Drug Conjugates (ADCs)**: Targeted cancer therapies that link monoclonal antibodies to cytotoxic drugs, minimizing side effects. - **Personalized Cancer Treatment**: First Ascent Biomedical's platform integrates drug testing, DNA/RNA sequencing, and AI to create tailored treatment plans. - **President's Cancer Panel report**: Highlights the potential of health technology to improve patient navigation in cancer care. - **Subcutaneous Injection Methods**: Emerging method in cancer treatment that offers cost savings and reduced administration times. - **Radiopharmaceuticals Growth**: The market for radiopharmaceuticals is projected to grow significantly, driven by advancements in targeted cancer treatments. - **Focused Ultrasound Technology**: Innovative approach to improve precision in targeting cancer while minimizing side effects. - **AI in Radiotherapy**: AI-assisted radiotherapy shows promise in improving treatment decisions for non-small cell lung cancer and liver cancer. ### Challenges and Concerns - **Financial Burden**: Cancer treatment is financially burdensome, necessitating financial assistance for many patients. - **Complexity of current cancer treatments**: Current methods often involve expensive combinations of molecules, making access to effective treatments challenging. - **Financial Toxicity**: The high costs of cancer treatments pose significant challenges for patient access and equity in care. - **Cardiovascular Toxicity**: Approximately one-third of cancer patients experience treatment-related cardiovascular toxicities, necessitating effective monitoring and management strategies. - **Treatment Resistance**: Significant issues persist in cancer therapies, with many tumors receiving inadequate drug treatment. - **Access to Personalized Treatments**: Ensuring equitable access to advanced cancer therapies remains a concern. - **High Costs of Treatment**: The financial burden of advanced cancer therapies, such as CAR T-cell therapy, which can exceed half a million dollars. - **High Costs of Treatments**: The high costs associated with innovative cancer therapies, including CAR T-cell treatments, pose a barrier to widespread adoption. - **Immunosuppressive Tumor Environments**: Challenges in optimizing NK cell expansion and overcoming these environments in cancer treatment. - **Drug Resistance in Cancer**: Ongoing research is needed to address drug resistance in breast cancer therapies and improve treatment strategies. - **Access to Personalized Care**: Efforts are being made to ensure personalized cancer care is accessible, particularly for underserved communities. - **Cost and Accessibility**: Concerns regarding the affordability and accessibility of advanced cancer treatments and diagnostics. - **Access to Technology**: Ensuring equitable access to cancer care technologies, particularly for elderly populations, remains a significant challenge. - **Health Disparities**: Efforts to address health disparities in cancer care, particularly for underserved populations, remain a critical concern. - **Access to Clinical Trials**: Efforts to democratize access to innovative cancer treatment trials in community settings. - **Access to CAR T-cell Therapy**: Efforts to make cellular therapies more accessible and equitable face challenges in healthcare systems. - **Onco-exceptionalism**: Concerns regarding the fairness of resource allocation and reimbursement for expensive cancer drugs. - **Clinical Trial Participation**: Less than 10% of cancer patients participate in clinical trials, highlighting the need for improved recruitment strategies. - **Regulatory Hurdles**: Concerns regarding the approval processes for new cancer therapies and the need for supportive regulatory frameworks. ## Related Topics [[Cancer Therapy]]; [[Cancer Immunotherapy]]; [[Cancer Screening]]; [[Cancer Diagnostics]]